Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. The PI3-kinase activity of this protein is not sensitive to nanomolar levels of the inhibitor wortmanin. This protein was shown to be able to be activated by insulin and may be involved in integrin-dependent signaling. [provided by RefSeq, Jul 2008]
PIK3C2A (Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Alpha) is a Protein Coding gene. Diseases associated with PIK3C2A include Oculoskeletodental Syndrome and Status Asthmaticus. Among its related pathways are Type II diabetes mellitus and PI Metabolism. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and phosphotransferase activity, alcohol group as acceptor. An important paralog of this gene is PIK3C2B.
PI 3-Kinases (phosphoinositide 3-kinases, PI 3-Ks) are a family of lipid kinases capable of phosphorylating the 3'OH of the inositol ring of phosphoinositides. They are responsible for coordinating a diverse range of cell functions including proliferation and survival.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000166 | nucleotide binding | IEA | -- |
GO:0005524 | ATP binding | IEA | -- |
GO:0016301 | kinase activity | IEA | -- |
GO:0016303 | 1-phosphatidylinositol-3-kinase activity | TAS,IDA | 9337861 |
GO:0016740 | transferase activity | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005634 | nucleus | IEA | -- |
GO:0005654 | nucleoplasm | IDA | -- |
GO:0005737 | cytoplasm | IBA,IDA | 21081650 |
GO:0005794 | Golgi apparatus | IEA | -- |
GO:0005802 | trans-Golgi network | IDA | 10766823 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | PI Metabolism |
.63
|
|
2 | superpathway of inositol phosphate compounds | ||
3 | Metabolism |
.40
|
|
4 | Apoptosis Pathway |
.39
|
|
5 | mTOR Pathway |
.38
.38
|
.32
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006661 | phosphatidylinositol biosynthetic process | TAS | -- |
GO:0006887 | exocytosis | TAS | 17371240 |
GO:0006897 | endocytosis | IMP | 21081650 |
GO:0007173 | epidermal growth factor receptor signaling pathway | TAS | 17371240 |
GO:0008286 | insulin receptor signaling pathway | TAS | 17371240 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Magnesium | Approved, Experimental, Investigational | Pharma | 0 | |||
Manganese | Approved | Nutra | 64 | |||
Wortmannin | Experimental | Pharma | PI3K inhibitor,selective and irreversible, Potent, irreversible inhibitor of PI 3-kinase. Also inhibitor of PLK1 | 0 | ||
3-Methyladenine | Experimental | Pharma | Class III PI3K inhibitor, Class III PI 3-kinase inhibitor; also inhibits autophagy | 0 | ||
Quercetin | Experimental, Investigational | Pharma | Antitumor agent, Non-selective PI 3-kinase inhibitor | 66 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
ADP |
|
58-64-0 | ||||
PS(14:0/14:0) |
|
|
||||
PS(14:0/14:1(9Z)) |
|
|
||||
PS(14:0/16:0) |
|
|
||||
PS(14:0/16:1(9Z)) |
|
|
Compound | Action | Cas Number |
---|---|---|
3-Methyladenine | Class III PI 3-kinase inhibitor; also inhibits autophagy | 5142-23-4 |
LY 294002 hydrochloride | Prototypical PI 3-kinase inhibitor; also inhibits other kinases | 934389-88-5 |
PI 103 hydrochloride | Inhibitor of PI 3-kinase, mTOR and DNA-PK | 371935-79-4 |
Quercetin | Non-selective PI 3-kinase inhibitor | 117-39-5 |
Wortmannin | Potent, irreversible inhibitor of PI 3-kinase. Also inhibitor of PLK1 | 19545-26-7 |
This gene was present in the common ancestor of animals and fungi.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | PIK3C2A 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | PIK3C2A 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | PIK3C2A 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Pik3c2a 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Pik3c2a 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | PIK3C2A 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | PIK3C2A 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | PIK3C2A 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | PIK3C2A 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | pik3c2a 30 |
|
||
Str.7067 30 |
|
||||
African clawed frog (Xenopus laevis) |
Amphibia | Xl.14586 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | pik3c2a 30 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Pi3K68D 30 31 32 |
|
OneToMany | |
African malaria mosquito (Anopheles gambiae) |
Insecta | AgaP_AGAP011036 30 |
|
||
Worm (Caenorhabditis elegans) |
Secernentea | piki-1 30 31 |
|
OneToMany | |
Baker's yeast (Saccharomyces cerevisiae) |
Saccharomycetes | VPS34 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 11 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
940979 | Uncertain Significance: not provided | 17,131,990(-) |
A/C NM_001321378.2(PIK3C2A):c.2157T>G (p.Asp719Glu) |
MISSENSE | |
940980 | Uncertain Significance: not provided | 17,097,233(-) |
T/C NM_001321378.2(PIK3C2A):c.4150A>G (p.Thr1384Ala) |
MISSENSE | |
rs138394492 | Benign: not provided | 17,168,713(-) |
T/C NM_001321378.2(PIK3C2A):c.1029A>G (p.Thr343=) |
SYNONYMOUS_VARIANT,INTRON | |
rs1565272952 | Pathogenic: Short stature; OCULOSKELETODENTAL SYNDROME | 17,145,862(-) |
C/A NM_002645.4(PIK3C2A):c.1640+1G>T |
SPLICE_DONOR | |
rs1565287817 | Likely Pathogenic: OCULOSKELETODENTAL SYNDROME | 17,169,157(-) |
A/C NM_001321380.2(PIK3C2A):c.-75-13528T>G |
NONSENSE,INTRON |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv2677594 | CNV | deletion | 23128226 |
esv3625466 | CNV | loss | 21293372 |
nsv467711 | CNV | gain | 19166990 |
nsv469762 | CNV | gain | 16826518 |
nsv477831 | CNV | novel sequence insertion | 20440878 |
nsv553567 | CNV | gain | 21841781 |
nsv553568 | CNV | gain | 21841781 |
nsv7691 | CNV | deletion | 18451855 |
nsv971989 | CNV | duplication | 23825009 |
Disorder | Aliases | PubMed IDs |
---|---|---|
oculoskeletodental syndrome |
|
|
status asthmaticus |
|
|
neuroleptic malignant syndrome |
|
|
leptospirosis |
|
|
acute kidney failure |
|
|